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Ectodomain (EC) shedding defines the proteolytic removal of a membrane pro-
tein EC and acts as an important molecular switch in signaling and other cellular
processes. Using tumor necrosis factor (TNF)a as a model substrate, we identify
a non-canonical shedding activity of SPPL2a, an intramembrane cleaving aspartyl
protease of the GxGD type. Proline insertions in the TNFa transmembrane (TM)
helix strongly increased SPPL2a non-canonical shedding, while leucine mutations
decreased this cleavage. Using biophysical and structural analysis, as well as mo-
lecular dynamic simulations, we identified a flexible region in the center of the
TNFa wildtype TM domain, which plays an important role in the processing of
TNFa by SPPL2a. This study combines molecular biology, biochemistry, and
biophysics to provide insights into the dynamic architecture of a substrate’s TM
helix and its impact on non-canonical shedding. Thus, these data will provide
the basis to identify further physiological substrates of non-canonical shedding
in the future.
INTRODUCTION
Ectodomain (EC) shedding is a non-reversible posttranslational modification that controls the level and
function of various membrane proteins by proteolytic removal of their extracellular/luminal domains
(Lichtenthaler et al., 2018). Canonical sheddases commonly cleave single-span transmembrane (TM) pro-
teins in the luminal juxtamembrane (JM) domain with a short distance to the TM domain (Ehlers and Rior-
dan, 1991). This results in release of a soluble EC, which can induce signaling in neighboring or even far
distant cells by interacting with cell surface receptors. Intramembrane proteases catalyze the hydrolysis
of peptide bonds in the plane of the membrane and typically release a short secreted peptide and an
intracellular fragment (ICD), which may translocate to the nucleus and induce signaling in the sub-
strate-expressing cell (Friedmann et al., 2006; Lichtenthaler et al., 2018; Mentrup et al., 2015; Nagase
and Nakayama, 2013).
Signal peptide peptidase (SPP) and its homologs, the SPP-like proteases (SPPLs), are aspartyl intramem-
brane proteases that are closely related to presenilins, which form the active subunit of the g-secretase
complex (Grigorenko et al., 2002; Ponting et al., 2002; Weihofen et al., 2002). The human genome encodes
five members of the SPP/SPPL family: SPP, SPPL2a, SPPL2b, SPPL2c, and SPPL3 (Grigorenko et al., 2002;
Ponting et al., 2002; Weihofen et al., 2002). Based on a conserved GxGD motif in one of their TM domains,
these proteases are also referred to as GxGD proteases (Haass and Steiner, 2002). The GxGDmotif harbors
one of the two catalytic aspartyl residues required for proteolytic activity (Bardy et al., 2003; Haass and
Steiner, 2002; LaPointe and Taylor, 2000). The second catalytic aspartyl residue is part of a (Y/F)D motif
located in the TM domain N-terminal of the GxGD motif. In contrast to presenilins that exclusively cleave
type I TM domains (Nout) (Hemming et al., 2008; Kopan and Ilagan, 2004), SPP/SPPLs are selective toward
TM segments in type II (Nin) orientation (Chen et al., 2014; Friedmann et al., 2004; Nyborg et al., 2004; Wei-
hofen et al., 2002). While currently more than 140 substrates have been assigned to the two human prese-
nilins (Güner and Lichtenthaler, 2020), only about 30 human substrates are known for all five SPP/SPPL fam-
ily members (Mentrup et al., 2017, 2019; Papadopoulou et al., 2019).iScience 23, 101775, December 18, 2020 ª 2020 The Authors.





ArticleThe so far known SPPL2a and SPPL2b substrates are mostly single-span TM proteins that are subject to
regulated intramembrane proteolysis (RIP), a two-step process that starts with EC shedding followed by
an intramembrane cleavage (Lichtenthaler et al., 2018). It is believed that in this context intramembrane
proteolysis occurs constitutively after canonical shedding has occurred, and, thus, EC shedding is the regu-
lating step in this process (Lichtenthaler et al., 2018).
A very well-characterized RIP substrate is tumor necrosis factor a (TNFa). Its canonical shedding is catalyzed by a
disintegrin and metalloprotease 17 (ADAM17), also known as TNFa-converting enzyme, and other membrane-
bound metalloproteases (Black et al., 1997; McGeehan et al., 1994). The soluble TNFa extracellular domain
(sTNFa) acts as a ligand for the TNFa receptors 1 and 2 that can either induce apoptosis or cell survival via several
pathways (Black et al., 1997; McGeehan et al., 1994). A short N-terminal TNFa fragment (TNFa NTF) remains
within the plasma membrane of the TNFa-expressing cell and can be processed further by SPPL2a or SPPL2b
(Fluhrer et al., 2006; Friedmann et al., 2006). Intramembrane proteolysis of the TNFaNTF starts with initial cleav-
ages at the C-terminal membrane boundary releasing TNFa C-peptide into the extracellular space. Subse-
quently, multiple processive intramembrane cleavages finally result in release of TNFa ICD into the cytosol (Fig-
ure 1A). While TNFa ICD has been suggested to induce IL-12 production in activated dendritic cells (Friedmann
et al., 2006), the function of the TNFa C-peptide remains enigmatic.
SPPL2b and presenilins only efficiently cleave their substrates either after a preceding EC shedding or if the
substrates’ EC is naturally short (Güner and Lichtenthaler, 2020; Martin et al., 2009). Membrane proteins
with an EC length exceeding 60 amino acids are not recognized as bona fide substrates by these proteases
(Martin et al., 2008; Struhl and Greenwald, 1999). Based on this, it was concluded that members of the
GxGD aspartyl proteases do not accept substrates with bulky long EC. However, just recently, SPPL3
has been demonstrated to act as a non-canonical sheddase as it accepts full-length (FL) glycosyltrans-
ferases and glycosidases directly as substrates and by that regulates the glycosylation status of many
cellular glycoproteins including those of the extracellular matrix (Kuhn et al., 2015; Voss et al., 2014).
Also, the cleavage of naturally short substrates by presenlin has been recently categorized as a non-canon-
ical shedding event (Lichtenthaler et al., 2018). One example of such a non-canonical shedding is the
processing of the B-cell maturation antigen which controls plasma cells in the bone marrow and yields a
potential biomarker for B-cell involvement in human autoimmune diseases (Laurent et al., 2015), high-
lighting the biological relevance of non-canonical shedding. However, so far, it is not known how intramem-
brane proteases recognize and process their substrates for non-canonical shedding.
Other thanmost solubleproteases, intramembraneproteases in thecontextofRIP typicallydonot recognize their
substrates by consensus sequences but rather seem to sense structural properties, including the dynamics of the
substrate’s TM helix (Hitzenberger et al., 2020; Langosch et al., 2015; Langosch and Steiner, 2017). For instance,
cleavage of the C-terminal b-amyloid precursor protein (APP) fragment (C99) by presenilin is influenced by the
local helical flexibility at the G37G38 hinge located in the N-terminal half of its TM domain (Barrett et al., 2012;
Götz et al., 2019b; Scharnagl et al., 2014). It has been proposed that a flexible TM helix facilitates translocation
of a substrate froman initial binding site of the enzyme toward its catalytic center (Langoschet al., 2015; Langosch
and Steiner, 2017). Furthermore, helix flexibility around the substrate’s initial cleavage sitesmay facilitate its local
unfolding,prior toendoproteolysisas suggestedbymutationalandstructural studies (Fernandezetal., 2016;Sato
et al., 2009; Zhou et al., 2019). In case of SPP/SPPL substrates, studies on a viral SPP substrate (Lemberg andMar-
toglio, 2002) andon theSPPL2b substrateBri2 (Fluhrer et al., 2012) indicate that specificglycine residues in theTM
domain of these substrates enhance their cleavability by SPP or SPPL2b, respectively.
Yet, due to lack of detailed studies on further substrates, it is not clear whether the dynamical properties of
the substrate’s TM helix are generally decisive to qualify a type II TM protein as SPPL2 substrate. This
prompted us to ask whether processing of TNFa by SPPL2a is similar to that observed for its close homolog
SPPL2b (Martin et al., 2009), if SPPL2 proteases would also be able to directly cleave TNFa FL and, if so,
what primary structure determinants and structural properties of the TNFa TM domain would affect this
non-canonical shedding.RESULTS
SPPL2a Mediates Non-canonical Shedding of TNFa
SPPL2a and SPPL2b have been shown earlier to be capable of processing the TNFaNTF that remains in the
plasma membrane after shedding by ADAM10/17 (Fluhrer et al., 2006; Friedmann et al., 2006). To test2 iScience 23, 101775, December 18, 2020
Figure 1. SPPL2a Cleaves Full-Length TNFa Independent of ADAM10/17-Mediated Shedding
(A) Schematic representation of TNFa processing. Full-length (FL) TNFa is shedded by ADAM10/17 (canonical shedding).
The remaining N-terminal fragment (NTF) is sequentially cleaved by SPPL2a or SPPL2b producing several intracellular
domains (ICDs) and a secreted peptide (C-peptide). In addition, SPPL2a cleaves TNFa FL directly before continuing with
the processive cleavage (non-canonical shedding).
(B) Non-canonical TNFa shedding by endogenous SPPL2a. TNFa ectodomains (ECs) were immunoprecipitated from
conditioned media of the HEK293 cell lines expressing endogenous (en.) levels of SPPL2a, SPPL2b, both or none (ko) and
visualized utilizing the C-terminal V5-tag. sTNFa(L2), TNFa EC secreted by SPPL2 mediated shedding; sTNFa, TNFa EC
secreted by ADAM mediated shedding.
(C) Ectopic SPPL2a expression (SPPL2a ex.) significantly increases sTNFa(L2) secretion. TNFa ECs were directly analyzed
from conditioned media. sTNFa(L2) was quantified relative to sTNFa from respective Western blots by densitometric
analysis and normalized to untreated controls, n = 3. Data are represented as mean G SD. Statistical significance was
calculated applying an unpaired, two-sided Student’s t test. *p < 0.05. The Western blot shows one representative
experiment.
(D) sTNFa(L2) secretion is blocked by an SPP/SPPL-specific inhibitor. TNFa ECs from conditioned media of the indicated
HEK 293 cell lines were isolated and detected as in (C). Cells were treated with either 50mM Z-LL2-ketone (+(ZLL)2) to
inhibit SPPL2 catalytic activity or with DMSO as a control (-(ZLL)2).
(E) sTNFa(L2) secretion is not affected by ADAM-specific inhibitors. TNFa ECs from conditioned media of the indicated
HEK 293 cell lines were isolated and detected as in (C). Cells were treated with either 5mM GI 254023X and 1mM BMS-
561395 (+AI) to inhibit ADAM proteases or with DMSO as a control (-AI).
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(F) Increased secretion of sTNFa does not affect sTNFa(L2) secretion. TNFa ECs from conditioned media of the indicated
HEK 293 cell lines were isolated and detected as in (C). Cells were treated with either 1mM phorbol 12-myristate 13-
acetate (PMA), 50mM (ZLL)2, 5mM GI 254023X, and 1mM 561395 (AI) or DMSO as control.
(G) Quantification of (F). sTNFa(L2) was quantified relative to intracellular TNFa FL by densitometric analysis fromWestern
blots as depicted in (F) and normalized to untreated controls; n = 3. Data are represented as mean G SD. Statistical




Articlewhether SPPL2 proteases in addition also accept TNFa FL as a substrate, TNFa was ectopically expressed
in T-Rex-293 (HEK293) cells. As expected, a prominent sTNFa fragment that is released by ADAM10/17 into
the conditioned media was detected (Figure 1B). However, in addition, a slightly larger TNFa fragment
(sTNFa(L2)) was secreted (Figure 1B). To evaluate whether this fragment results from cleavage by
SPPL2a/b, we generated HEK293 cells that either only express endogenous SPPL2b or SPPL2a or lack
both proteases using CRISPR/Cas9 (Figure S1A and S1B). Cells that only express endogenous SPPL2a still
secreted sTNFa(L2), comparable to cells that express both proteases, while the protein fragment was ab-
sent in conditioned media of cells that only express SPPL2b or none of the two proteases (Figure 1B). To
further support sTNFa(L2) generation by SPPL2a and to exclude that its production by SPPL2b was not
only missed due to low endogenous SPPL2b expression, we ectopically co-expressed TNFa and either
SPPL2a or SPPL2b and analyzed the conditioned media (Figure 1C). Ectopic expression of SPPL2a signif-
icantly enhanced sTNFa(L2) secretion compared to control cells (Figure 1C). In contrast, ectopic expression
of SPPL2b did not significantly change sTNFa(L2) secretion (Figure 1C). This indicates that sTNFa(L2) is
generated by SPPL2a mediated non-canonical shedding, while SPPL2b even under over-expression condi-
tions is hardly capable of non-canonical TNFa shedding.
Treatment of cells with 2,20-(2-Oxo-1,3-propanediyl)bis[N-[(phenylmethoxy)carbonyl]-L-leucyl-L-leucin-
amide ((Z-LL)2-ketone), an SPP/SPPL-specific inhibitor, significantly reduced generation of sTNFa(L2), while
sTNFa secretion was not changed significantly (Figures 1D and 1G). In contrast, treatment of these cells
with an ADAM10/17-specific inhibitor (AI) resulted in a significant reduction of sTNFa, while sTNFa(L2) re-
mained unchanged compared to the respective non-treated cells (Figures 1E and 1G). Treatment with
phorbol 12-myristate 13-acetate, which stimulates canonical shedding by ADAM proteases, as expected,
specifically increased sTNFa, but not sTNFa(L2), release (Figures 1F and 1G), indicating that sTNFa(L2)
secretion is independent of sTNFa secretion, suggesting that ADAM10/17 and SPPL2a are not competing
for cleavage of TNFa wildtype (wt).
Non-Canonical TNFa Shedding Occurs at Similar Cleavage Sites as Intramembrane Cleavage
Since it is not known whether SPPL2a intramembrane cleavage in the context of RIP follows the same prin-
ciples as SPPL2b intramembrane cleavage, we analyzed SPPL2a-mediated TNFa cleavage in comparison to
its processing by SPPL2b.
To allowmonitoring of all intramembrane cleavage products, different TNFa variants were used (Figure 2A).
To visualize secreted TNFa C-peptides and thus the initial SPPL2 cleavage, a C-terminally V5-tagged TNFa
variant, lacking the EC (TNFa NTF), was used. Co-expression of the TNFa NTF and SPPL2b resulted in
secretion of TNFa C-peptides that were absent in cells lacking endogenous SPPL2 expression (Figure 2B).
SPPL2a acted similarly and triggered the secretion of comparable TNFa C-peptide amounts (Figure 2B),
suggesting that the initial endoproteolytic processing step after canonical shedding occurs with similar ef-
ficiency by both proteases. To monitor TNFa ICD production, N-terminally Flag-tagged TNFa FL was co-
expressed with either SPPL2a or SPPL2b. As demonstrated before, SPPL2b co-expression resulted in effi-
cient generation of a TNFa ICD that goes along with reduction of the TNFa NTF (Figure 2C) (Fluhrer et al.,
2006, 2008). Similarly, co-expression of TNFa FL and SPPL2a resulted in conversion of TNFaNTF into TNFa
ICD, while upon expression of TNFa FL in SPPL2a/b double knock-out cells, no TNFa ICD species were de-
tected (Figure 2C). To address whether SPPL2a similar to SPPL2b utilizes processive cleavages within the
TM domain to release TNFa ICD species, we performed in vitro conversion assays as described earlier
(Fluhrer et al., 2008). Membrane preparations from cells co-expressing either SPPL2a or SPPL2b and
TNFa FL were incubated at 37C for different time intervals. Similar to SPPL2b, SPPL2a evinced processive
activity, converting longer TNFa ICD species into shorter ones (Figure 2D). Using matrix-assisted laser
desorption/ionisation – time of flight (MADLI-TOF) mass spectrometry, we determined whether cleavage
sites of both SPPL2 proteases in TNFa are similar. Mass spectrometry of TNFa ICDs produced by SPPL2b
from cleavage of TNFa FL confirmed the cleavage sites after amino acids S34 and L39 in the TM domain and4 iScience 23, 101775, December 18, 2020
Figure 2. Processing of TNFa by SPPL2a Compared to SPPL2b
(A) Amino acid sequences and schematic representation of all TNFa variants used. Arrows indicate the peptides detected
by mass spectrometry in (E).
(B) C-peptide secretion in SPPL2-expressing cells. C-peptides were immunoprecipitated from conditioned media of
HEK293 cell lines expressing exogenous (ex.) levels of SPPL2a, SPPL2b, or none of the proteases (ko) and ectopically
expressing the TNFa NTF using the polyclonal V5 antibody. For visualization on Western blot, the monoclonal V5
antibody was employed.
(C) ICD generation in SPPL2-expressing cells. Membranes of the indicated HEK293 cell lines ectopically expressing TNFa
FL were isolated. Visualization of intracellular TNFa species was done by the monoclonal Flag antibody. Calnexin served
as a loading control.
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(D) Processive turnover of TNFa by SPPL2 proteases. Membranes of HEK293 cell lines co-expressing either SPPL2a or
SPPL2b and TNFa FL were incubated for the indicated time periods. ICD conversion was monitored using Western blot
and the Flag M2 antibody for detection. Calnexin served as a loading control.
(E) N-terminal SPPL2 cleavage sites in TNFa. Mass spectrometric analysis of ICDs generated from SPPL2a or SPPL2b,
respectively. Numbers indicate the position of the most C-terminal amino acid of the respective cleavage product. *
marks background peak also present in control (see Figure S2).
(F) C-terminal SPPL2 cleavage sites in TNFa. Mass spectrometric analysis of C-peptides generated from SPPL2a or





Articlethe release of additional smaller peptides ranging from 18 to 28 amino acids in length as reported before
(Figures 2E and S2) (Fluhrer et al., 2006). In addition to our earlier study, we now, due to increased sensitivity
of the mass spectrometry analysis, identified an additional consecutive cleavage site at Ser37 (Figure 2E).
TNFa ICDs released by SPPL2a were qualitatively similar (Figure 2E), but cleavage after S34 occurred more
efficiently in SPPL2a-expressing cells compared to SPPL2b-expressing cells. In contrast, cleavage after L39
was the dominant intramembrane cleavage product in SPPL2b-expressing cells (Figure 2E). To allow mass
spectrometric detection of TNFaC-peptides, we used a TNFaNTF version that carries a Flag-tag stabilized
by alanine and proline at the C-terminus (TNFa NTF-AP; Figure 2A). Analysis of TNFa C-peptides released
by SPPL2b confirmed the two major cleavage sites at L50 and H52 (Figures 2F and S2) (Fluhrer et al., 2006).
Additionally, two smaller C-peptides resulting from cleavages at V55 and R60 were identified (Figures 2F
and S2). Both C-peptide species were not detected in our initial study (Fluhrer et al., 2006) since they do
not contain any of the amino acids that were used to label the cleavage products radioactively. These C-
peptides emerge from cleavages in the luminal JM domain of TNFa. Although we cannot finally exclude
that these shorter C-peptides originate from unrelated exopeptidases present in the conditioned media,
the pattern observed suggests that SPPL2b-mediated endoproteolysis also occurs in the luminal JM
domain in close vicinity to the TM domain. SPPL2a essentially secreted the same C-peptide species,
although the shorter C-peptide species were less abundant (Figures 2F and S2).
Based on this, we next analyzed whether the SPPL2a non-canonical shedding that results in sTNFa(L2)
secretion occurs at the same positions as the cleavages that release TNFa C-peptides in the context of
RIP. To determine the N-termini of the soluble TNFa species, we established a TNFa FL version that
harbors an internal Flag-tag followed by a TEV protease (isolated from Tobacco Etch Virus) cleavage
site C-terminally of the amino acid that terminates TNFa NTF (TNFa FlagTEV; Figure 3A). Processing of
TNFa FlagTEV by SPPL2a essentially resembled that of TNFawt (Figure 3B), and transport of TNFa FlagTEV
to the cell surface occurred with similar efficiency as that of TNFa wt (Figure S3A). To analyze the cleavage
sites of SPPL2a in TNFa FlagTEV, cleavage products were isolated from conditionedmedia by immunopre-
cipitation utilizing the Flag-tag. The isolated protein fragments were subjected to TEV-protease cleavage;
peptide fragments containing a Flag-tag were again immunoprecipitated and subjected to MALDI-TOF
mass spectrometry. The analysis revealed two groups of peptides, one reflecting cleavages at the known
SPPL2 sites (Fluhrer et al., 2006, Figure 2F) and the other comprising much smaller peptides that match the
known ADAM10/17 cleavage sites (Figures 3C, S3B, and S3C) (Mohan et al., 2002). To ensure that the group
of larger peptides was indeed generated by SPPL2a cleavage, cells were treated with the SPP/SPPL inhib-
itor (Z-LL)2-ketone prior to analysis. As expected, secretion of all peptides ranging from 4 to 6 kDa was
strongly reduced, while secretion of peptides resulting from ADAM10/17 cleavage remained unchanged
(Figure 3D). Thus, we conclude that SPPL2a non-canonical shedding occurs at the same cleavage sites
as cleavage of TNFa by SPPL2a in the context of RIP. Interestingly, however, the most dominant cleavage
site of SPPL2a non-canonical shedding mapped to cleavage at V55, while the dominant cleavage sites of
intramembrane cleavage were detected at L50 and H52 (Figure 2F).The Primary Structure of the TNFa TM Domain Affects Non-Canonical Shedding
Earlier studies suggested that intramembrane proteolysis by GxGD-aspartyl proteases is affected by the
conformational flexibility of a substrate’s TM helix (Fluhrer et al., 2012; Götz et al., 2019b; Langosch
et al., 2015; Langosch and Steiner, 2017). To elucidate whether similar determinants also influence
SPPL2a-mediated non-canonical shedding of TNFa, all serines (S34, S37), glycines (G43), cysteine (C49),
and histidines (H52) in the TNFa TM domain were substituted by alanine, leucine, or proline. While glycine
residues facilitate local helix bending and change its collective dynamics (Högel et al., 2018), polar residues
form stabilizing hydrogen bonds that potentially form between their side chains and the main-chain6 iScience 23, 101775, December 18, 2020
Figure 3. Cleavage Sites of SPPL2a-Mediated Non-Canonical TNFa Shedding
(A) Amino acid sequence and schematic representation of TNFa FlagTEV. Arrows indicate the cleavage sites of the
respective proteases.
(B) Processing of TNFa wt and TNFa FlagTEV is essentially similar. Membranes of HEK 293 cells co-expressing SPPL2a
(SPPL2a ex.) and the indicated TNFa variant were analyzed on Western blot using the monoclonal Flag M2 antibody to
detect all intracellular TNFa fragments. The respective conditioned media were visualized with the monoclonal V5
antibody to detect secreted TNFa EC variants.
(C and D) Cleavage sites of the secreted TNFa ectodomain variants. Secreted EC from HEK 293 cells co-expressing
SPPL2a and TNFa FlagTEV were treated with 50mM (ZLL)2 (D) or DMSO (C). Numbers indicate the position of the most
N-terminal amino acid of the respective cleavage product. Peaks from 66 to 77 reflect cleavage of TNFa by ADAM




Articlecarbonyl oxygens of upstream residues (Gray and Matthews, 1984; Scharnagl et al., 2014). Alanine or
leucine can rigidify a TM helix by non-polar interactions of its flexible side chain with neighboring residues,
whereby the effect of leucine on helix stabilization is supposed to be stronger than that of alanine (Quint
et al., 2010). In contrast, proline destabilizes TM helices, as it cannot form an amide hydrogen bond and its
cyclic side chain clashes with its N-terminal neighbor (Cordes et al., 2002).
All TNFamutants were co-expressed at similar amounts with SPPL2a in HEK293 cells (Figure 4A). Substitu-
tions of S34, S37, G43, and C49 by proline significantly enhanced SPPL2a-dependent non-canonical TNFa
shedding, while an H52P mutation had no effect (Figures 4A and 4B). In contrast, leucine substitutions at all
positions decreased non-canonical SPPL2a shedding, with C49L and H52L having the strongest effect (Fig-
ures 4A and 4B). Alanine substitutions at all positions had only minor impact on non-canonical shedding.
Similar to the G37/G38 hinge of the APP TM helix (Götz et al., 2019b), G43 may increase helix flexibility at
the center of the TNFa TM domain. Interestingly, an even stronger helix destabilization at this position by
the G43P mutation caused the most pronounced increase in non-canonical shedding. In contrast, the
attempt to stabilize this site by the G43L mutation had only a very minor effect. Since the destabilizing func-
tion of glycine results from a packing defect due to its missing side chain (Högel et al., 2018), we reasoned
that the small side chain of both neighboring alanine residues might also contribute to local helix flexibility.
This compares to the sequence context of the G37G38 hinge of the C99 TM helix, where the GG motif is
flanked by insufficiently packing VAL residues V36, V39, V40 (Götz et al., 2019b; Hitzenberger et al.,
2020). Consequently, we replaced the A42G43A44 motif by leucine residues (TNFa AGA/LLL). Indeed, this
resulted in an almost complete loss of SPPL2a-mediated non-canonical shedding (Figures 4C and 4D).iScience 23, 101775, December 18, 2020 7
Figure 4. Modulating Non-Canonical Shedding by Mutations in the TM Domain
(A) Mutations in the TM domain of TNFa affect non-canonical shedding by SPPL2a. Secreted TNFa from media of cells co-expressing SPPL2a (SPPL2a ex.),
and the respective TNFamutant was analyzed using the V5 antibody. Detection of TNFa FL frommembranes served as a transfection control and calnexin as
a loading control.
(B) Quantification of (A). sTNFa(L2) was quantified relative to sTNFa from respective Western blots by densiometric analysis and normalized to TNFa wt, n =
3. Data are represented as mean G SD. Statistical significance was calculated applying an unpaired two-sided Student’s t-test. *p < 0,05.
(C) Insertion of a triple L motif reduces SPPL2a shedding. sTNFa from TNFa wt and the AGA/LLL variant was detected with the V5 antibody in media of cells
co-expressing SPPL2a.
(D) Quantification of (C). sTNFa(L2) was quantified relative to sTNFa from respective Western blots by densiometric analysis and normalized to TNFa wt, n =




ArticleAlthough SPPL2b does not act as a non-canonical sheddase on TNFa wt (Figure 1), proline substitutions at
positions S34, S37, as well as G43, allowed non-canonical shedding also by SPPL2b (Figure S4).
These data demonstrate that proline mutations that disturb helical geometry of TM domains support non-
canonical shedding of TNFa, while leucine mutations tend to have the opposite effect. Interestingly,
leucine substitutions had the strongest impact in the C-terminal part of the TM domain, while the increase
of non-canonical shedding by proline substitutions in the N-terminal half was most pronounced.
Mutations Affecting the Efficiency of TNFa Cleavage by SPPL2a Do Not Alter the Cleavage
Sites
To elucidate whether increased non-canonical shedding induced by proline substitutions also affected the
SPPL2a cleavage sites, we performed mass spectrometric analysis of the respective TNFa C-peptides. Pro-
line substitutions that significantly increased non-canonical shedding of SPPL2a (S34P, S37P, G43P, and
C49P) did not change SPPL2a cleavage sites (Figure 5). Interestingly, H52P, which had no effect on cleavage8 iScience 23, 101775, December 18, 2020
Figure 5. Cleavage Sites of SPPL2a in TNFa Mutants Are Not Changed
Secreted C-peptide was immunoprecipitated from media of HEK293 cells co-expressing SPPL2a with anti-Flag M2 affinity gel and analyzed via mass




Articleefficiency, resulted in an almost complete loss of the major cleavages sites at leucine 50 and histidine 52,
and cleavage at V55 became the major cleavage product (Figure 5). In contrast, C49P, which also changes
an amino acid directly at one of themajor cleavage sites, did not result in loss of a specific cleavage product
(Figure 5). While proline substitutions at S34 and S37 relatively increased cleavage at H52, the proline sub-
stitution at G43 relatively increased cleavage at R60 (Figure 5).
These data indicate that initial cleavage of SPPL2a at H52 is more dependent on certain primary sequence
requirements than, for instance, cleavage at C49, and disruption of the a-helix at H52 seems not to be toler-
ated by SPPL2a. In addition, proline substitutions in the N-terminal half of the TNFa TM domain affected
the preferred position of the initial cleavage at the C-terminal membrane border, pointing to distance ef-
fects of these mutations.
Since proline substitutions increased non-canonical TNFa shedding to levels comparable with the physio-
logically very important canonical shedding (Figures 4A and 4B) (Brenner et al., 2015; So and Ishii, 2019), it is




Articleto identify such substrates, e.g., by use of tailored prediction algorithms, we aimed to characterize the
dynamical and structural changes induced by these mutations using deuterium/hydrogen exchange
(DHX), NMR spectroscopy, and molecular dynamic (MD) simulations.Deuterium/Hydrogen Exchange Suggests a Central Flexible Region in the TNFa wt TM Helix
Using DHX kinetics, we investigated selected mutants that drastically affected the efficiency of non-canon-
ical shedding by SPPL2a and were designed to change the conformational flexibility of the TNFa TM helix.
Specifically, we compared TNFawt to S34P, themost N-terminal mutation that significantly increased initial
cleavage at the C-terminal end, and to S34A, which did not affect non-canonical shedding, as well as to
AGA/LLL, which significantly reduced SPPL2a non-canonical shedding. DHX was recorded on correspond-
ing synthetic peptides that included the complete predicted TNFa TM domain and parts of the JM do-
mains (Figure S5A), including naturally occurring basic residues that improve solubility of the peptides.
As done previously (Pester et al., 2013), DHX kinetics of exhaustively (>95%) deuterated peptides were
measured at 20C and pH 5 in 80% (v/v) trifluoroethanol (TFE), a solvent that supports helicity and the
low content of water mimics the aqueous environment near the catalytic residues of aspartate intramem-
brane proteases (Sato et al., 2006). In contrast to membrane-embedded peptides, TFE allows effective ex-
change from hydrophobic residues (Poschner et al., 2009).
First, we examined the overall DHX kinetics of the peptides. At the start, when labile deuterons bound to
polar or non-H-bonded heavy atoms have already exchanged to protons,25 amide deuterons remain, i.e.
90% of those 28 backbone amides that can be partially protected from DHX by intrahelical H-bond for-
mation (Figure S5B). Over time, isotope patterns gradually shifted and the isotopic distributions lacked a
bimodal shape (data not shown). This behavior is diagnostic of EX2 kinetics where individual deuterons are
exchanged in an uncorrelated fashion, thus indicating transient local helix unfolding events (Konermann
et al., 2011; Xiao et al., 2005). The overall exchange kinetics of TNFa wt and S34A peptides were similar,
while the exchange rate in S34P was higher and it was strongly reduced in AGA/LLL (Figure S5B). In the sec-
ond step, we employed gas-phase fragmentation by electron transfer dissociation after different periods of
DHX in order to resolve amide H-bond strength of the helices at the single-residue level. From the DHX
kinetics of the fragment ions, we determined the residue-specific free energy changes DG associated
with the disruption of amide H-bonds (Figure 6A) based on the amide exchange rate constants kexp (Fig-
ure S5B and Table S1) (Yucel et al., 2019). Some amides (T46, L50) are described only insufficiently due to
poor fragmentation efficiencies and/or overlap of isobaric fragments.
The DG values obtained for the TNFa wt TM helix range from1 kcal/mol to4.5 kcal/mol. Values of1 kcal/
mol werepreviously reported for intrahelical H-bonds inwater, which areweak since intrahelical H-bonding com-
petes with helix-water H-bonding,4 kcal/mol for H-bonds ofmodel compounds in apolar solvent, and 6.6 kcal/
mol for H-bonds in vacuo (Bowie, 2011). In the standard amide H-bonding pattern of an a-helix, the nitrogen of a
residue at position (i) forms H-bonds to the carbonyl oxygens at residues (i-3) and (i-4). Thus, in the TNFa helix,
nitrogens of T45, L47, and F48 formH-bonds with V41/A42, G43/A44, andA44/T45 carbonyls, respectively. Inter-
estingly, their stabilities are1 kcal/mol below those of their neighbors. This is consistent with the existence of a
flexible region from V41 to T45 (Stelzer and Langosch, 2019). Glycine and, by analogy, alanine induce a local
packing defect which can facilitate helix bending (Högel et al., 2018), which in turn destabilizes H-bonding to
upstream (i,i+3,4) amides, as observed here. The L47/F48 carbonyls also formed low stability (i+3,4) H-bonds
with L51.Onlyminordifferences inH-bond strength in theN-terminal regionwereobservedbetween the amides
of TNFawt and the S34Amutant (Figure 6B). In contrast, the S34Pmutationmarkedly weakenedH-bonds in that
region, in particular between F36 and L39 (Figure 6B).DG values around position 34 could not be determined as
exchange is too rapid for experimental resolution close to the frayed helix termini. Importantly, compared to
TNFawt, the AGA/LLLmutant exhibited amarkedly enhancedH-bond strength ranging from I40 up to the initial
cleavage siteof SPPL2a atC49, which effectively compensates the reductions ofH-bond stability seenwith thewt
(Figure 6B).
In summary, these data indicate the presence of a flexible region in the center of the TNFa wt TM domain
that may reflect a potential hinge region, similar to that observed in the APP TMdomain (Barrett et al., 2012;
Götz et al., 2019b). S34P induces a significant destabilization in the N-terminal part of the TNFa TM helix up
to the potential hinge region. In contrast, the AGA/LLL mutation resulted in a marked stabilization in the
center of the TM helix. However, these data do not explain the distance effect of S34P on the C-terminal
cleavage site that was observed in the cellular cleavage assays.10 iScience 23, 101775, December 18, 2020
Figure 6. Analysis of TNFa TM Helix Flexibility by DHX
(A) Calculated Gibb’s free energy differences DG of amide H-bond disruption of the TNFa wt TM helix. Error bars
correspond to standard confidence intervals (calculated from the errors of fit in kexp determination). Broken lines denote
the major initial SPPL2a cleavage sites.
(B) Differences DDG between TNFamutant and wt amides (Gconfidence intervals of mutants). Confidence intervals of wt
amides are plotted in light gray on the x axis. In the case of the colored bars, the confidence intervals of mutant and wt are




ArticleNMR Spectroscopy Reveals the Structure of the TNFa TM Helix and the Impact of Mutations
on a Central Bend
To further interpret the data obtained from DHX kinetics and to unravel the distance effect on the C-ter-
minal cleavage site, we determined the 3D structures of TNFa wt, the S34P, and the AGA/LLL mutant
TM domain peptides (Figure 7A) in TFE:H2O (80:20, v:v) by NMR spectroscopy. Amino acids which take
part in an a-helical conformation show short-range cross peaks between amide protons (dNN(i, i+1)), Ha
and amide protons (daN(i, i+3)), as well as Ha and Hb protons (dab(i, i+3)) in 1H1H-NOESY spectraiScience 23, 101775, December 18, 2020 11
Figure 7. 3D Structural Analysis of the TNFa TM Segment by NMR
(A) Solution structures of TNFa wt (black), TNFa S34P (green), and TNFa AGALLL (orange). The A42/G43/A44 motif is represented in red (wt and S34P),
respectively, in pink in AGA/LLL. P34 in S34P is shown in pink.
(B) Structural bundles of TNFa wt (black), TNFa S34P (green), and TNFa AGA/LLL (orange). Top and side views of the 20 best structures superimposed onto
the backbone of C-terminal helix from residue 42 to 53. The A42/G43/A44 motif is represented in red. Amino acid exchanges in the respective mutants are
highlighted in magenta.
(C) Backbone conformations of NMR structures. Top section: Probability that a residue is part of a single hinge (type Bend 1) or a pair of hinges (type Bend 2).
Dashed lines indicate cleavage sites. Bottom section: Bend 1 and Bend 2 subsets aligned to an ideal reference helix (gray cylinder). The hinges (green) are
coordinating bending between helical segments. Bend 1 structures were aligned to the helical C-terminal segment of the reference structure (gray cylinder);
Bend 2 conformations were aligned to the helical segment between the two hinges. The location of S34 and S37 Ca atoms is highlighted as purple spheres.
Mutation sites are drawn in space fill mode (Leu: red, Pro: black). Exemplary conformations illustrating the fundamental motions are explained in more detail
in (Götz et al., 2019b; Götz and Scharnagl, 2018).
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Article(Figure S6A) (Wüthrich, 1986). Further, deviations of chemical shifts from random coil values, denoted as
secondary chemical shifts Dd, are sensitive to protein secondary structure, with helical conformation result-
ing in positive secondary shifts of 13Ca (Wishart et al., 1991) and negative secondary shifts of 1Ha, as well as
13Cb (Spera and Bax, 1991; Wishart et al., 1991).
In the TNFawt peptide, the pattern of dNN(i, i+1), daN(i, i+3), and especially dab(i, i+3) NOE peaks, as well
as secondary chemical shifts, indicated a helical segment ranging from residue C30 to F53 (Figure S6). The
3D structure revealed a slight bend in the center of the helix at the A42/G43/A44 motif (Figure 7A). In this
region, secondary chemical shifts and the number of characteristic dab(i, i+3) NOE peaks were reduced,
supporting a disturbance of the a-helix (Figure S6). Furthermore, the presence of daN(i, i+2) NOEs in
this region is indicative for a 310-helix contribution. The 310-helix has been proposed as an intermediate
in folding and unfolding of a-helices and therefore suggests a disruption of a regular a-helix (Millhauser,
1995; Wüthrich, 1986). The N-terminus of the a-helix, and in particular its first turn (L31 to L35), showed a
lower number of dab(i, i+3) NOEs and less pronounced secondary chemical shifts, while the C-terminal he-
lical part (T45 to F53) formed amore stable a-helix reflected by a regular pattern of characteristic NOEs and
higher secondary chemical shifts (Figure S6). The side chain g-hydroxyl proton of T45 showed a clear reso-
nance and an NOE contact to the methyl group of V41. Since this hydroxyl proton is in H-bonding distance
to the main chain carbonyls of V41 or A42, it might stabilize the a-helix at A42. This side chain/main chain H-
bond might also promote the bend in the middle of the helix. The orientation of the N-terminal TM part
with respect to the C-terminal part was not static, but slightly flexible, whereby the mutual orientation of
the two parts was not arbitrary (Figure 7B). To visualize the flexibility of the TNFa TM domain, we superim-
posed the NMR models onto the backbone of the C-terminal part from A42 to F53. This revealed that the
orientation of the N-terminal part with respect to the C-terminal part cannot be fully restrained. Yet, the
mutual orientation of the two helical regions underlies constraints as the N-terminal helices are located
within a narrow cone with A44 lying on the convex side of the bend (Figure 7B).
In the S34P mutant, the helix started N-terminally at P34 and, thus, is a full helical turn shorter than in the wt
structure (Figure 7A). The region between C30 and P34 was characterized by very long amide H-bonds and
a severely distorted structure as indicated by secondary chemical shifts and the NOE pattern (Figure S6).
Additionally, daN(i, i+2) NOEs and the presence of daN(i, i+4) NOEs in the N-terminal helix (P34 to V41)
may be interpreted as a mixture of random coil and a-helix, as well as a mixture of 310-helix and a-helix.
As expected, this indicated a less stable or more distorted a-helix (Millhauser, 1995), which comprises
greater flexibility compared to the TNFa wt TM domain. As in TNFa wt, the side chain g-hydroxyl proton
of T45 marks the beginning of the C-terminal part and revealed an NOE contact to the methyl group of
V41. Interestingly, the bend in the center of S34P was less pronounced (Figure 7A). Consequently, the
S34P mutation not only resulted in a shortened N-terminal helix but also straightened the entire TNFa
TM helix. Superposition of S34P structures onto the backbone of the C-terminal part indicates that the
N-terminal part lies within a smaller cone. Interestingly, they bend in a different direction in comparison
to TNFa wt, and A44 now lies at the concave side and A42 on the convex side of the bend (Figure 7B).
Similar to the TNFa wt TM domain, the AGA/LLL mutant formed an a-helix from C30 to F53, but, as ex-
pected, the central region containing the leucine substitutions was more stable, as indicated by the sec-
ondary chemical shifts and NOE pattern (Figure S6). In addition to the T45 side chain g-hydroxyl proton,
that of T46 also showed an NOE contact to the methyl group of L4. This suggests that this T46 hydroxyl
hydrogen forms an H-bond to the main chain carbonyls of leucines at position 42 or 43, reflecting a
more stable structure of AGA/LLL in accordance with the DHX experiments. By superimposing the struc-
tures of the AGA/LLL mutant onto the backbone of the C-terminal part ranging from L42 to F53, the N-ter-
minal part is found within a comparable cone as in TNFawt (Figure 7B). However, the bulky leucine residues
bend the helix in direction of V41/T45 (Figure 7B). This effect may especially be transmitted through the two
adjacent threonines (T45, T46). Since their side chain hydroxyl groups form hydrogen bonds to the main
chain (V41, A42, and A43), any change in their orientation affects the direction of the N-terminal helix.
A quantitative characterization of the NMR conformational ensembles with respect to location of mechan-
ical hinges using the program Dyndom complements this analysis (Götz et al., 2019a, 2019b; Hayward and
Lee, 2002). In this context, in order to act as hinge, a flexible region (R 2 residues) has (i) to be flanked by
more rigid helical segments, and (ii) to be part of an intact H-bond network that coordinates the motions of




Articleparts of helical peptides can bend and twist around a single hinge, which is referred to as Bend1 and Twist1
motions, respectively. In another conformational subset, the terminal helix segments bend or twist with
respect to the helical center segment around a pair of hinges, which is referred to as Bend2 and Twist2 mo-
tions, respectively. Steric conformation of the side chain, as well as stability of H-bonds spanning the hinge
and connecting it with the flanks, determines extent and direction of conformational changes.
For the TNFawt peptide andAGA/LLLmutant, Bend1 andBend2 conformations are equally probable, while the
S34Pmutants prefer single-hingebending.Helix twistingwas not observed. In theBend1 conformationsof TNFa
wt, the hinge is located at V41A42 in the helix center (Figure 7C). The S34P and the AGA/LLL shift the Bend1
hinge downstream to T45/T46 or A42/G43, respectively. These residues also form part of the double hinge in
Bend 2 conformations, where the second hinge is located in the N-terminal part of the helix and shifts from
S37/F38/L39 in TNFa wt to F36/S37 in the AGA/LLL mutant and F38/L39 in S34P (Figure 7C). Besides the muta-
tion-induced hinge shifts, we also observe differences with respect to the extent of bending. For TNFa wt, the
mean bending angle between the helical segments is25 for both Bend1 and Bend2 conformations. The S34P
mutation reduces bending to10, while the AGA/LLLmutation allows for a10 larger bending. TNFawt and
the AGA/LLL mutant show the same preference for the direction of bending.
In line with the DHX experiments (Figure 6), the NMR data demonstrate that S34P destabilizes the N-ter-
minal part of the TNFa TM helix, while the AGA/LLL mutation stabilized its central region. N- and C-termi-
nal parts of the TNFa wt TM domain adapt a defined relative orientation to each other. Most likely, this is
facilitated by a flexible, but still helical, bend in the center of the TM domain. Interestingly, the S34P mu-
tation induced a straighter orientation of the two parts, while the AGA/LLL induced a C-terminal shift of the
bend and slightly changed the extent and direction of the bend (see below). This may explain the distance
effects observed in the cleavage assays (Figure 4).MD Simulations Predict Impact of Mutations on TM Helix Tilt and C-Terminal Residue
Insertion in a Membrane
In order to study TM helix dynamics in a membrane, we performed microsecond atomistic MD simulations
of the TMFa wt TM helix (residues 22–62), as well as the S34A, S34P, and AGA/LLL mutants, in a fully hydrat-
ed 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) bilayer.
All mutations affected the orientation of the TM helix (F36-C49) with respect to the membrane normal (Fig-
ures 8A and 8C). The S34A and S34P mutations were predicted to increase the tilt angle from an average of
15 in the TNFa wt peptide to 50 in the mutants, while the AGA/LLL mutation induces a second pop-
ulation tilting with 35 in the simulation. An increased tilt angle goes along with an increased membrane
insertion depth of residues at the C-terminal interface (Figures 8A and 8B) which would in turn stabilize the
helix and increase its length as predicted by secondary structure analysis using the DSSP algorithm (Fig-
ure S7A) (Kabsch and Sander, 1983). Orientation of the TM domain, as well as location of the cleavage
site, might have an impact on the initial encounter of the substrate’s TM domain with the enzyme. However,
neither simulated tilt angle distributions nor helix lengths show a clear correlation to the cleavage effi-
ciencies of the respective mutants.
Next, we investigated the occupancy of intrahelical H-bonds, i.e., the probability of a backbone carboxyl at
position i forming a a-H-bond or a 310-H-bond with an amide in either i+4 or i+3. For the TNFa wt and all
mutants, a slightly lower occupancy of a-H-bonds emanating from L35/F36/S37 backbone carboxyl was
calculated (Figure S7B), which is compensated by formation of 310-H-bonds (Figure S7C). For residues at
the C-terminal membrane interface, i.e., the region of the initial SPPL2a cleavage sites, notable shifting
from a- to 310-H-bonds was detected, where the onset of a-H-bond instabilities correlates with residue
insertion depths. Interestingly, in the S34P mutant, the percentage of these 310-H-bonds was lower and
slightly C-terminally shifted, which may produce functional TM helix flexibility (Cao and Bowie, 2012).
Finally, we applied the same method as for analysis of the NMR conformational ensembles to investigate
helix flexibility in terms of hinge bending and twisting motions of the TNFa peptides in a POPC membrane
bilayer. While the S34P mutation introduces a structural kink, i.e., a strong permanent bending around a
hinge localized at L33/P34 in >70% of the structures, deviations from a straight helix in TNFa wt, S34A,
and AGA/LLL are <30%, distributed over three helix turns and involve four different conformational classes
with per-residue hinge propensities <10% (Figure 8D). Constraints imposed by the lipid environment14 iScience 23, 101775, December 18, 2020
Figure 8. TNFa TM Helix Dynamics in a POPC Bilayer from MD Simulations
(A) Residue insertion depths relative to the lipid phosphate heads. Gray areas represent the location of the phosphate heads. The dots indicate the average
Ca position (larger dots specify helical residues as determined by secondary structure analysis, see Figure S7). Dashed lines indicate cleavage sites.
(B) Distribution of tilt angle between the TM-helix (F36-C49) and the membrane normal. The colored areas show the 95% CI.
(C) Representative structures illustrating the orientation in the membrane. Red spheres show lipid phosphates.
(D) Backbone conformations of TNFa wt andmutant TM helices characterized by the probability that a residue is part of a single hinge (types Bend 1, Twist 1)




Articlerestrict backbone flexibility to low-amplitude bending and twisting (with average screw angles 10 and
root mean-squared fluctuations around the average structure0.5 A) (Figure S7D). Since per-residue hinge
propensities <10% are close to the background noise of the applied method, the impact of mutations on
preferred backbone conformations can only be roughly characterized. The S34A mutation seems to abro-
gate twisting over the whole TM helix, while the AGA/LLL mutation appears to preferentially diminish
twisting of the C-terminal TM helix part.
Taken together, helix orientation and C-terminal residue insertion in the POPC membrane seem to be
dependent on S34. This pronounced distance effect suggests that the hydroxyl group of the N-terminal
S34 side chain can act as an anchor for the TNFa TM helix and might even be a key factor for lateral inter-
actions with the enzyme. With the exception of the structural kink induced by the S34P mutant, large de-
viations from a straight helix are unlikely. H-bonds spanning the region from L35/F36/S37 to L39/I40/V41
show slightly increased flexibility. Instabilities of H-bonds in this region were also detected with DHX




ArticleC-terminal membrane interface close to the initial SPPL2a cleavage sites. In both cases, TM domain flexi-
bility is supported by a- to 310-H-bond shifting.DISCUSSION
This study demonstrates a non-canonical shedding activity of SPPL2a onwt TNFa, which was not observed for its
close homolog SPPL2b (Figure 1). The latter observation is in line with previous studies, where SPPL2b and pre-
senilins efficiently process only substrates with rather short ECs (Güner and Lichtenthaler, 2020; Martin et al.,
2009; Struhl and Greenwald, 1999). In addition, SPP efficiently cleaves signal peptides only after they have
been released from nascent secretory or membrane proteins by signal peptidase (Lemberg and Martoglio,
2002). SinceSPPL2a andSPPL2bare close homologs and share a very similar cleavagemechanismwithpresenilin
(Figure 2) (Langosch and Steiner, 2017), it was surprising that SPPL2a is capable of processing a substrate with a
long and bulky EC. However, SPPL3, a more distant homolog to SPPL2a and SPPL2b (Voss et al., 2013), was
recently identified as ‘‘bona fide’’ non-canonical sheddase among GxGD proteases. SPPL3 accepts a number
of different glycosyltransferases and glycosidases without prior shedding and, other than SPPL2b, also cleaves
the FL foamy virus envelope protein (Kuhn et al., 2015; Voss et al., 2012, 2013). Moreover, it has been recognized
that SPP in context of Endoplasmic-reticulum-associated protein degradation (ERAD) assembles into high-mo-
lecular-weight complexes, which enables it to act as a ‘‘part-time’’ non-canonical sheddase (Boname et al., 2014;
Chen et al., 2014; Hsu et al., 2015; Stagg et al., 2009; Stefanovic-Barrett et al., 2018). Further, presenilins can also
process substrates with long ECs, although with rather low efficiency (Boname et al., 2014; Chen et al., 2014; Hsu
et al., 2015; Laurent et al., 2015; Lichtenthaler et al., 2018; Schauenburg et al., 2018; Stagg et al., 2009; Stefanovic-
Barrett et al., 2018). Interestingly, SPPL3 is the smallest member of the GxGD-protease family, comprising a very
short N-terminus and does not undergo glycosylation (Friedmann et al., 2004). Substrate entry into SPPL3 may
thus experience the least steric hindrance within the GxGD protease family. In contrast to SPPL3, both SPPL2a
and SPPL2b comprise a large and highly glycosylated N-terminal domain, which faces the lumen/extracellular
space, but only SPPL2b carries an additional glycosylation site on the loop connecting the active site containing
TM domains 6 and 7 (Friedmann et al., 2004). This additional glycosidic chain, which also faces the lumen/extra-
cellular space, may be responsible for the stricter size exclusion of SPPL2b compared to SPPL2a. Other than all
SPP/SPPL family members, presenilins associate with three additional membrane proteins (nicastrin, Aph-1, and
Pen-2) in a high-molecular-weight g-secretase complex in order to become fully catalytically active (Prokop et al.,
2004). Structural analysis of the g-secretase complex indicates that nicastrin, which comprises a highly glycosy-
lated ectodomain, forms a lid on top of the active site of presenilin (Bai et al., 2015) and, thus, most likely hinders
entry of substrates with bulky ECs to the active site (Bolduc et al., 2016).
In light of SPPL2a acting as a non-canonical sheddase, it may be speculated that, in principle, all GxGD pro-
teases are capable of accepting substrates with rather long ECs to some extent, but protease intrinsic steric
properties or the presence of bulky co-factors restrict entry of such substrates. Consequently, non-canon-
ical sheddase efficiency among human GxGD proteases may be ranked as follows:
SPPL3>SPPL2a > SPPL2b > SPP > presenilin
However, to finally proof the proposed hierarchy of non-canonical shedding efficiency, further studies will
be required.
SPPL2a non-canonical shedding occurs at the same cleavage sites as hydrolysis of TNFaNTF, which results in the
liberation of TNFaC-peptide (Figure 3). However, while themajor initial cleavage site in TNFaNTFwasmapped
at L50, non-canonical shedding of TNFa FLmainly occurred at V55. Thismay suggest that either bindingof TNFa
FL to the SPPL2a active site occurs slightly differently than binding of the TNFaNTF. Alternatively, the lack of its
bulky ECmay position the TNFaNTF in the membrane such that access to the cleavage site at L50 is optimized.
Western blot analysis of samples independently treated with SPP/SPPL inhibitor or ADAM10/17 inhibitor (Fig-
ure 1) indicated that non-canonical SPPL2a shedding occurs independently from canonical ADAM10/17 shed-
ding of TNFa wt. Although the level of ADAM shedding appeared to be decreased by the G43P mutation in
TNFa, we assume that this decrease resulted indirectly from an enhanced SPPL2a processing rate.
Non-canonical TNFa shedding by SPPL2a is greatly facilitated by proline substitutions in the TNFa TM
domain. Of note, the strongest increase of non-canonical shedding was achieved by proline substitutions
in the N-terminal and central part of the TNFa TM domain (Figure 4). DHX analysis and NMR structural anal-




Articlewhich is predominantly a-helical in TNFa wt (Figure 7). Interestingly, destabilization in the N-terminal part
of the TM helix induced increased cleavage by SPPL2a at the C-terminal end of the helix (Figure 5). In line
with this, only removal of a potentially helix-destabilizing glycine residue in the N-terminal part of the Bri2
TM domain significantly reduced cleavage by SPPL2b at its C-terminal end, while mutating glycines in the
C-terminal part of the Bri2 TM domain had no effect (Fluhrer et al., 2008). In addition, cleavage of CD74 by
SPPL2a was reduced by simultaneous substitution of all potentially helix-destabilizing glycine residues in its
TM domain. The CD74 TM domain comprises two glycines in the N-terminal part and one in the C-terminal
part; however, the role of the individual glycine residues was not investigated (Hüttl et al., 2016).
Inorder tounderstandthe long-distanceeffectofS34P, its structurewascomparedtothatof theTNFawtTMhelix
by NMR spectroscopy. The TNFa wt TM helix is slightly bent and flexible at its center at an A42/G43/A44 motif
where it tends to form a 310 helix (Figures 7 and 8). Bending of the helix is consistent with lower amide H-bond
stabilities from T45 to F48, as detected by DHX, which suggests longer amide H-bonds toward residues within
the bend. This may reflect an overall curvature of the helix around a central hinge region as indicated by the
distributed hinge propensities in a quantitative evaluation of the NOE data (Figure S6) and the NMR conforma-
tional ensembles (Figure 7). Similar to TNFa, the G37G38 hinge in the APP TMhelix is also distant from the initial
ε-cleavage sites of g-secretase (Götz et al., 2019b). Of note, bending and the deviation from the ideal TM helix
geometry in case of TNFa are much less pronounced than for the APP TM helix (Figure 7 ; Silber et al., in press).
The S34P mutation strongly destabilizes the N-terminal part of the TM helix and shifts the dominant hinge
bending to A42 and G43. Although located distant to the potential hinge region, the S34P mutation resulted
in increased H-bond flexibility, as detected by DHX (Figure 6), and a less pronounced bend and, thus, a more
linear orientationofN- andC-terminal helix parts (Figure 7).MDsimulationof the S34P in a POPCbilayer predicts
an increase in the tilt angle of the helix within a lipid bilayer compared to TNFa wt, concomitant with a deeper
residue insertion (Figure 8) anda lowerpercentageof 310-H-bonds in the regionof cleavage (FigureS7). Together
with the impact of S34P on the flexibility and positioning of the hinge region, this may explain the long-distance
effect observed for cleavage of S34P and likely other proline substitutions in this region.
In contrast, the AGA/LLL substitution strongly reduced non-canonical shedding by SPPL2a (Figure 4) and
resulted in a broad helix stabilization from I40 through C49 (Figure 6). This concurs with a shift of the hinge
propensity from the center of the TM helix toward T45/T46 that allows for larger bending resulting in a
different mutual orientation of the N- and C-terminal part of the helix (Figure 7). However, this did not
destabilize downstream amide H-bonds to an extent that was detectable by DHX. These data are reminis-
cent of previous findings where stabilizing the flexible G37G38 hinge within the APP TM domain by a
glycine-to-leucine mutation significantly reduced its cleavage by g-secretase (Götz et al., 2019b). In addi-
tion, reducing the conformational flexibility of the XBP1u TM helix reduced its cleavage by SPP, although
increasing helix flexibility had no effect (Yucel et al., 2019).
How do those changes in the structure and dynamics of the TM helix translate into the significantly
enhanced non-canonical shedding of S34P and the abolished cleavage of AGA/LLL, respectively (Figure 4)?
Our present data and the previous findings on APP indicate that a hinge near the center of a substrate’s TM
domain may be beneficial for substrate processing. For g-secretase, substrate processing starts with its
recognition at one or more exosites in the g-secretase complex followed by translocation of the initial
cleavage sites to the enzyme’s active site, where the substrate docks prior to local unfolding, bond hydro-
lysis, and product release. It has been proposed that a flexible APP TM helix may be required for multiple
steps of processing, in particular for substrate translocation to the catalytic site (Langosch et al., 2015; Lan-
gosch and Steiner, 2017). Recent substrate docking experiments indicate transient TM helix kinking at the
di-glycine motif of the C99 TM domain during the first step of substrate entry, where the N-terminal part of
the helix already occupies its final binding sites while the C-terminal part begins to bypass the cytosolic
loop of g-secretase (Hitzenberger et al., 2020). To finally proof whether these findings fully translate to sub-
strate recognition by SPP/SPPL proteases, the 3D structures of the enzymes will be required.
Themajor initial cleavage sites at L50 andH52are locatedwithin stableC-terminal helical sectionsof theTNFaTM
domain (Figures 6and7).While theS34PorAGA/LLLmutations significantly changedtheefficiencyof non-canon-
ical shedding (Figure 4), they did not affect the structure or H-bond stability directly at the cleavage site (Figures 6
and 7). Introducing potentially helix-destabilizing C49P or H52Pmutations directly at the cleavage site had only a
minor or no effect on cleavage efficiency, while introducing aC49L or H52Lmutation reduced cleavage efficiency




Articlepeptidebondhydrolysis.However, it is currently unclearwhether the leucinemutations exert their inhibitory effect
via stabilizing thehelix around the scissilebondorvia interferingwith thedockingof the substrate into theenzyme.
Recent cryo-EMstructures forg-secretase incomplexwithNotch1orAPPCTF showed that substrate helix unfold-
ing at the initial cleavage sites was induced and stabilized by the formation of a hybrid b-sheet composed of
b-strands in PS1 and in the substrate’s TM domain, downstream to the initial cleavage sites (Götz et al., 2019a,
2019b). Since, at present, no structural data of any SPP/SPPL family member in complex with a substrate is avail-
able, it remainsenigmaticwhether TNFaundergoesa similar interactionwith theenzyme,which induces substrate
unfolding.However,basedonsequenceanalysis, theb-strandofPS1maybeconserved inallmembersof theSPP/
SPPL familywhich suggests a conservedmechanism requiring local substrate dockingandunfolding for bothpro-
tease families, including a requirement for amino acid sequence determinants as it has been discussed for sub-
strate docking to SPP (Lemberg and Martoglio, 2002; Yucel et al., 2019).
Under physiological conditions, SPPL2a-mediated non-canonical TNFa shedding most likely only yields a
small amount of total secreted TNFa. Since SPPL2a is mainly active in lysosomes (Schröder et al., 2010), it
may be speculated that TNFa FL, which escapes processing by ADAM10/17 on the cell surface, is endocy-
tosed and shed by SPPL2a in the lysosome. To explain subsequent secretion of sTNFa(L2a), sorting in exo-
cytic vesicles similar to, for instance, the LDL receptor (Wijers et al., 2015) may be postulated.
In light of the efficient non-canonical sheddingof someofour TNFamutants, it is tempting to speculate that hith-
erto unknownphysiological type-II TM substrates exist that are primarily cleaved by non-canonical SPPL2a shed-
ding. We suggest the following requirements for these substrates: (i) The TM helix must exhibit flexibility in its
N-terminal region and (ii) a flexible hinge region in theN-terminal or central region.We speculate that the profile
of backbone flexibility of a substrate TMhelix depends on the types of cognate aspartate protease. Possibly, the
degree of helix flexibility may match the extent of steric hindrance presented by the enzyme. For example,
SPPL2b, which exhibits a greater intrinsic steric hindrance for substrate entry, may require a more pronounced
helical flexibility of the substrate’s TM domain to overcome this steric barrier. In other words, the more pro-
nounced the steric barrier of the intramembrane protease, the more flexibility in the substrate’s TM domain
may be required to allow efficient entry of substrates to the active site of the intramembrane protease.
This study identifies a cleavage of SPPL2a in TNFa, which reflects a non-canonical shedding. Thus, a slightly
longer TNFa EC is released from the TNFa-expressing cell. Whether this fragment holds different signaling
capacities than soluble TNFa produced from canonical ADAM10/17 shedding or simply allows the cell to
degrade cell surface TNFa FL that escaped canonical shedding remains to be investigated. By combining
cell biology, biochemical, and structural analysis, we provide evidence that non-canonical shedding of
SPPL2 substrates is facilitated by flexibility in a part of the TM helix distal to the cleavage site, including
a non-linear orientation of its N- and C-terminal parts. The preferred orientation of both parts depends
on a flexible hinge in the center of the TM. The position of the hinge in the TM domain depends on
sequence context. We expect that an improved understanding of the structure and dynamics of non-
canonically shedded GxGD protease substrates will aid their future prediction from primary structure.
Limitations of the Study
At present, the in vivo relevance of non-canonical TNFa shedding is not understood. Since TNFa process-
ing in mice seems to be fundamentally different, as multiple fragments released by ADAM-dependent ca-
nonical shedding are detectable, it is currently not possible to unambiguously identify SPPL2a-dependent
non-canonical shedding in mousemodels. In order to identify non-canonical TNFa shedding in human cells
reliably, a SPPL2a-deficient macrophage cell line would be needed. Thus, at this stage, the in vivo relevance
of TNFa non-canonical shedding remains enigmatic.
In addition, it would be of interest whether mutations that alter TNFa non-canonical shedding occur in a
physiological or pathophysiological context. However, so far, no TNFa variations have been documented
that could account for such processing defects. Single-nucleotide polymorphisms have only been reported
in the promotor region of the TNFa gene accounting mostly for altered expression levels.
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Högel, P., Götz, A., Kuhne, F., Ebert, M., Stelzer,
W., Rand, K.D., Scharnagl, C., and Langosch, D.
(2018). Glycine perturbs local and global
conformational flexibility of a transmembrane
helix. Biochemistry 57, 1326–1337.
Hsu, F., Yeh, C., Sun, Y., Chiang, M., Lan,W., Li, F.,
Lee, W.-H., and Chau, L.Y. (2015). Signal peptide
peptidase-mediated nuclear localization of heme
oxygenase-1 promotes cancer cell proliferation
and invasion independent of its enzymatic
activity. Oncogene 34, 2360–2370.
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Table S1: ETD D/H exchange data, Related to Figure 6 
Numerical values of kexp and ∆G 
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e log kexp 
[min-1] 
        ∆G 
   [kcal/mol] 
R29 n.d.2  ● n.d.  ● n.d.  ● n.d.  
C30 n.d.  ● n.d.  ● n.d.  ● n.d.  
L31 n.d.  ● n.d.  ● n.d.  ● n.d.  
F32 n.d.  ● n.d.  ● n.d.  ● n.d.  
L33 n.d.  ● n.d.  ● n.d.  ● n.d.  
S34 n.d.  A n.d.  P --  ● n.d.  
L35 n.d.  ● n.d.  ● n.d.  ● n.d.  
F36 -0.57 ± 0.07 1.2 ± 0.10 ● -1.31 ± 0.15 2.2 ± 0.20 ● 0.34 ± 0.28 (-2.1 ± 2.2) ● -0.59 ± 0.22 1.2 ± 0.34 
S37 -1.03 ± 0.09 3.0 ± 0.11 ● -1.25 ± 0.16 3.3 ± 0.22 ● 0.44 ± 0.06 1.0 ± 0.17 ● -0.75 ± 0.06 2.7 ± 0.08 
F38 -1.21 ± 0.17 2.8 ± 0.22 ● -1.94 ± 0.31 3.8 ± 0.41 ● -0.19 ± 0.09 1.4 ± 0.19 ● -1.20 ± 0.21 2.8 ± 0.29 
L39 -2.54 ± 0.25 3.8 ± 0.34 ● -2.51 ± 0.26 3.7 ± 0.35 ● -1.34 ± 0.10 2.2 ± 0.19 ● -2.78 ± 0.26 4.1 ± 0.35 
I40 -2.81 ± 0.10 3.6 ± 0.13 ● n.d.  ● -2.42 ± 0.19 3.1 ± 0.30 ● -3.74 ± 0.18 4.8 ± 0.25 
V41 -2.88 ± 0.15 3.7 ± 0.20 ● -2.73 ± 0.09 3.5 ± 0.13 ● -2.56 ± 0.08 3.3 ± 0.14 ● -3.78 ± 0.10 4.9 ± 0.14 
A42 -2.58 ± 0.27 4.3 ± 0.36 ● -2.91 ± 0.11 4.8 ± 0.15 ● -2.33 ± 0.11 4.0 ± 0.23 L -3.88 ± 0.23 5.3 ± 0.31 
G43 -2.17 ± 0.23 4.3 ± 0.31 ● -2.63 ± 0.15 5.0 ± 0.20 ● -1.69 ± 0.09 3.7 ± 0.24 L -4.01 ± 0.16 5.4 ± 0.22 
A44 -2.13 ± 0.13 4.3 ± 0.18 ● -2.47 ± 0.13 4.6 ± 0.18 ● -1.75 ± 0.12 3.6 ± 0.20 L -3.97 ± 0.18 5.3 ± 0.25 
T45 -1.99 ± 0.14 3.6 ± 0.19 ● n.d.  ● -1.86 ± 0.12 3.5 ± 0.21 ● -3.88 ± 0.35 5.9 ± 0.46 
T46 n.d.  ● n.d.  ● -1.84 ± 0.09 3.7 ± 0.18 ● -3.67 ± 0.23 6.2 ± 0.31 
L47 -1.99 ± 0.24 3.2 ± 0.32 ● n.d.  ● -1.89 ± 0.07 3.1 ± 0.15 ● -3.36 ± 0.48 5.1 ± 0.64 
F48 -1.94 ± 0.31 3.1 ± 0.42 ● -2.13 ± 0.42 3.3 ± 0.57 ● -1.79 ± 0.17 2.9 ± 0.23 ● n.d.  
C49 -1.99 ± 0.22 4.6 ± 0.29 ● n.d.  ● -1.59 ± 0.11 4.0 ± 0.30 ● -2.83 ± 0.27 5.7 ± 0.36 
L50 n.d.  ● n.d.  ● -1.57 ± 0.19 3.0 ± 0.44 ● n.d.  
L51  -2.08 ± 0.31 2.8 ± 0.42 ● n.d.  ● n.d.  ● -2.47 ± 0.59 3.3 ± 0.80 
H52 -2.13 ± 0.15 4.7 ± 0.20 ● n.d.  ● n.d.  ● -1.94 ± 0.49 4.4 ± 0.66 
F53 -1.36 ± 0.26 3.7 ± 0.35 ● -1.82 ± 0.32 4.3 ± 0.43 ● -1.17 ± 0.21 3.4 ± 0.34 ● -1.15 ± 0.18 3.4 ± 0.24 
G54 -0.75 ± 0.11 2.5 ± 0.15 ● -0.67 ± 0.18 2.4 ± 0.26 ● -0.68 ± 0.17 2.4 ± 0.23 ● -0.55 ± 0.16 2.2 ± 0.22 
V55 n.d.  ● n.d.  ● -0.82 ± 0.16 1.4 ± 0.27 ● n.d.  
I56 n.d.  ● n.d.  ● n.d.  ● n.d.  
G57 n.d.  ● n.d.  ● n.d.  ● n.d.  
P58 --  ● --  ● --  ● --  
Q59 n.d.  ● n.d.  ● n.d.  ● n.d.  
R60 n.d.  ● n.d.  ● n.d.  ● n.d.  
 
1 Identity of the TMD peptide 
2 n.d. = not determined  
3 kexp from exponential fit of means ± SE 








Molecular cloning and cDNA constructs 
The cDNAs that encode SPPL2a and SPPL2b and a C-terminal HA-tag have been described 
earlier (Martin et al., 2008). TNFα wt and TNFα NTF comprise N-terminal Flag and a C-terminal 
V5 tags and have been described earlier (Fluhrer et al., 2008). Mutated TNFα cDNAs were 
either cloned via quick change PCR or purchased at IDT. After the starting methionine an N-
terminal FLAG tag (DYKDDDDK) and, at the C-terminus of the protein, a V5 tag 
(GKPIPNPLLGLDST) were added. The PCR products or gBlocks were subcloned into the 
HindIII and XhoI sites of a pcDNA3.1 Hygro(+)  vector (Life Technologies, Hennigsdorf).  For 
MALDI TOF analysis tags were swapped, the V5 tag was added N-terminally and a FlagAP 
tag (DYKDDDDKAP) C-terminally (TNFα NTF-AP). 
TNFα Flag-TEV was designed by adding a Flag Tag and a TEV cleavage site (ENLYFQG) 
one helix turn (4 AA) after the ADAM cleavage site at position 77.  All primer sequences are 
available upon request, and all expression constructs were sequence-verified prior to 
experimental use.  
 
Cell lines and cell culture 
T-RexTM-293 (HEK293) (Invitrogen, Hennigsdorf, Germany) were cultured in DMEM with 
Glutamax (Invitrogen, Hennigsdorf, Germany) supplemented with 10% fetal calf serum 
(Sigma), 1% penicillin/streptomycin (Gibco) and 5µg/ml Blasticidin (Invitrogen, Hennigsdorf, 
Germany).  
HEK293 cells stably expressing ectopic SPPL2a or SPPL2b have been described earlier 
(Martin et al., 2008). Of note, these cells endogenously express SPPL2a and low levels of 
SPPL2b. Cells were cultured in DMEM with Glutamax (Invitrogen, Hennigsdorf, Germany) 
supplemented with 10% fetal calf serum (Sigma), 1% penicillin/streptomycin (Gibco), 5µg/ml 
Blasticidin (Invitrogen, Hennigsdorf, Germany) and 10 µg/ml Zeocine (Invitrogen, Hennigsdorf, 
Germany). To induce expression of the SPPL2 constructs, cells were incubated with 1 µg/ml 
doxycycline (BD Biosciences, San Jose) added to an otherwise antibiotic free medium at least 
24 h before transient transfection of the SPPL2 substrates. Transient transfections of cells 
were carried out using Lipofectamine 2000 (Invitrogen, Hennigsdorf, Germany) according to 
the manufacturer’s instructions. To inhibit protease function inhibitors were added into the 
culture media for 24h ((Z-LL)2 ketone, ADAM inhibition: GI254023X, Merck, Darmstadt, BMS-
561392, provided kindly by Haass Lab). 
 
Generation of knock out cells  
Guide RNAs targeting the SPPL2a or SPPL2b gene were purchased from Sigma-Aldrich 
(Darmstadt, Germany; 01111718MN, 11091608MN). For SPPL2a two human GFP-tagged 
guide RNAs both binding in exon 1 were tested. SPPL2b GFP-tagged guide RNA was chosen 
to bind in exon 4 to target all different splice variants. HEK293 cells were transiently transfected 
with the respective guide RNAs and submitted to FACS based single cell sorting and sorted 
for their GFP signal.  Protease knockdowns were validated with PCR followed by sequencing 
and SPPL2a knockdown was additionally confirmed on protein level using Western Blot 
analysis. SPPL2a/b double knockout was achieved by transfecting HEK293 SPPL2b knockout 
cells with SPPL2a guide RNA. Validation was carried out as for the single SPPL2a knock out 
cell line. Potential off target effects were excluded using NCBI Nucleotide BLAST.  
 
Membrane isolation, immunoprecipitation and immunoblotting  
Cells were harvested on ice and lysed in ice-cold hypoton buffer (10mM Tris, 1mM EDTA, 
1mM EGTA, pH 7.6) supplemented with protease inhibitor mix (1:500) (P1860, Sigma Aldrich, 
Darmstadt, Germany). Membranes were isolated by centrifugation at 16.000 x g and 
resuspended in basic buffer (40mM Tris,40mM potassium acetate, 1.6mM magnesium 
acetate, 100mM sucrose, 0.8mM DTT). Samples were incubated as indicated in the respective 
figure. Subsequently proteins were precipitated with chloroform/ methanol (2:1) and 
resuspended in sample buffer (10% (v/v) glycerol, 7.5% (w/v) SDS, 7.5% (w/v) DTT, traces of 
bromophenol blue, dissolved in 4x upper Tris (0,5M Tris, 0,8% (w/v) SDS pH6.8)). For 
immunoprecipitation cells were harvested on ice and lysed in ice-cold STE buffer (150 mM 
NaCl, 50 mM Tris (pH 7.6), and 2mM EDTA) supplemented with 1% (v/v) NP-40, 1% (v/v) 
Triton X-100 and protease inhibitor mix (1:500). Anti-Flag® M2 affinity gel (Sigma-Aldrich, 
Darmstadt, Germany) was used to precipitate TNFα FL and all intracellular cleavage products. 
Secreted ectodomains were precipitated from conditioned media using V5 polyclonal AB3792 
(Thermo Fisher, Hennigsdorf, Germany) and protein G sepharose beads (GE Healthcare, 
Solingen, Germany). Isolated proteins were washed 3 times with STEN lysis buffer (50mM Tris 
HCl ph7.6, 150mM NaCl, 2mM EDTA pH 8, 0.2µM NP-40), sample buffer was added, and 
samples were incubated 10 min at 95°C. 
For separation of intracellular TNFα species and TNFα C-peptides a modified Tris-Tricine gel 
was used (Fluhrer et al., 2006). Secreted TNFα ectodomain species were separated on 12% 
SDS-PAGE. Samples were blotted on PVDF or – for cleavage products smaller than 6 kDa - 
on nitrocellulose membranes. Blocking unspecific antibody binding was performed by using a 
commercial kit (Thermo Fisher, Hennigsdorf, Germany) according to the manufacturer’s 
instructions.  Primary antibodies (Flag M2®, Sigma-Aldrich, Darmstadt, Germany, V5 
monoclonal R960-25, Invitrogen, Hennigsdorf, Germany, SPPL2a 6E9, (Voss et al., 2012)) as 
indicated in the respective figures were incubated overnight at 4°C, secondary antibodies were 
added 1h at RT, Blots were detected using PierceTM ECL Western Blotting Substrate (Thermo 
Fisher, Hennigsdorf, Germany) or Westar Antares (Cyanagen, Bologna, Italy).  
 
Mass Spectrometry 
Secreted protein species were precipitated as described above. Isolated peptides were 
washed 3x with MS-washing buffer (0,14M NaCl, 0,1% N-octyleglycopyranoside, 10mM Tris-
HCl pH 7,6, 5mM EDTA) and 2x with dH2O. For detection of cleavage sites in TNFα FlagTEV 
the isolated peptides were eluted from the beads with 100mM glycine pH 2.5 and cleaved with 
AcTEV according to the manufacture’s instructions (Invitrogen, Hennigsdorf, Germany). The 
cleaved peptides were precipitated with Flag Agarose for 1h followed by 3 washes with MS-
washing buffer and 2 washes with dH2O. For ICD detection, membranes were incubated for 
45 min at 37 °C, solubilized in SPP stock buffer (50mM Tris HCl ph7.8, 50mM potassium 
acetate, 2mM magnesium acetate, 125mM sucrose, 1mM DTT) supplemented with 2% DDM 
and incubated 30 min on ice before centrifugation at 16.000 x g. Peptides were 
immunoprecipitated using Anti-Flag® M2 affinity gel. Immunoprecipitates were washed 3 times 
with MS-washing buffer and twice with dH2O.  Samples were subjected to analysis by mass 
spectrometry using a α-cyano-4-hydroxycinnamic acid matrix (Sigma Aldrich, Darmstadt, 
Germany) mixed 1:1 with acetonitrile and 0,6% TFA. Three times 0,4 µl of sample was spotted 
on a 384 spot plate and left to dry at room temperature. Mass spectra were recorded on a 4800 
MALDI TOF/TOF analyzer (Applied Biosystems, Hennigsdorf, Germany) in the linear mode 
with external calibration. 
 
Peptide synthesis 
Peptides for D/H exchange (DHX) comprising AA 28 to 60 of TNFα were synthesized by Fmoc 
chemistry (PSL, Heidelberg, Germany or Zhengzhou Peptides Pharmaceutical Technology 
Co., Ltd., Zhengzhou, China) and purified by HPLC. Purity was > 90% as judged by mass 
spectrometry. Concentrations were determined via UV spectroscopy using an extinction 
coefficient at 205 nm of 142 900 M-1·cm-1. All other chemicals were obtained from Sigma-
Aldrich Co. (St. Louis, Missouri, USA). 
For solution NMR experiments N-terminal acetylation and C-terminal amidation of TNFα28-60 
was used. TNFα wt, S34P, and AGA/LLL peptides were purchased from the Core Unit Peptid-
Technologien, University of Leipzig, Germany, with a purity of >90 % as judged by mass 
spectrometry. 
 
Deuterium/Hydrogen exchange experiments and Electron Transfer Dissociation D/H-
exchange 
Prior to DHX and Electron Transfer Dissociation D/H-exchange (ETD-DHX) peptides were 
deuterated in 80% (v/v) d1-HFIP/20% D2O at a concentration of 300 µM and incubated at 37°C 
for 7 days. To avoid contamination with dissolved polypropylene from reaction tubes, glass 
inserts were used in 1.5 ml safe-lock tubes. After 7 days, the solution was put in a new reaction 
tube and the solvent was removed by SpeedVac centrifugation. The remaining peptide pellet 
was dissolved in 80% (v/v) d1-TFE in 2 mM ND4-acetate. Deuterated dithiothreitol (DTT) 
(prepared by repeated dissolution of DTT in D2O, overnight lyophilization and dissolving the 
deuterated DTT in D2O) was used at a final concentration of 1 mM to reduce the disulfide 
bridges of the cysteines in the deuterated samples. This prevents considerable dimerization of 
the peptides by disulfide bonds upon prolonged storage in TFE and HFIP as was detected by 
mass spectrometry. Finally the deuteration level was > 95%.  
 
For global DHX measurements, the deuterated peptides were diluted 1:20 from a 100 µM 
deuterated peptide stock solution in 80% (v/v) TFE in 2 mM NH4-acetate (+ 0.5 mM tris(2-
carboxyethyl)phosphine (TCEP)), pH 5.0 (peptide final concentration: 5 µM) and incubated for 
different time periods (t = 0,1 min, 2 min, 5 min, 10 min, 20 min, 1 h, 2 h, 4h, 8 h, 16 h, 24 h, 
48 h, 72 h) in 0.5 ml Eppendorf safe-lock tubes (Eppendorf, Germany)  at 20°C in a thermal 
cycler (MasterCycler from Eppendorf, Germany). To slow down the exchange reaction before 
measurement, samples were quenched by putting them on ice and adding formic acid (0.5% 
(v/v) final concentration) which lowered the pH to ≈2.5. Mass/charge (m/z) ratios were recorded 
after the indicated time periods using a Synapt G2 HDMS mass spectrometer (Waters Co., 
Milford, MA) with one scan/second. The calculation of equilibrium constants was done for a 
standard situation of exchange in pure water. The absolute values obtained for Keq may thus 
be overestimated due to a number of factors as detailed elsewhere (Stelzer et al., 2016). 
Nonetheless, these factors influence DHX of all TMDs tested in a similar fashion, thus, allowing 
their comparison.  
 
For ETD-DHX measurement, a solution of deuterated peptide (100 µM) was diluted 1:20 with 
protonated solvent (80% (v/v) TFE in 2 mM NH4-acetate (+ 1 mM TCEP), pH 5.0 (standard pH 
5.0 or other pH values) to a final peptide concentration of 5 µM and incubated at 20°C in a 
thermal cycler (MasterCycler® from Eppendorf, Germany). 10-11 different incubation times 
from 0.1 min at pH 4 (corresponding to 1 min at pH 5.0) up to 3.95 h at pH 6.5 (corresponding 
to 125 h at pH 5.0) were applied. ETD was conducted by injecting the cooled and quenched 
peptide samples with a 100 µl gas-tight Hamilton syringe (a flow rate: 5 µl/min) and a short 
PEEK-tubing with a needle port.  During the measurement, the syringe was cooled down by a 
-20°C cool pack. The ETD MS/MS measurements were carried out in sensitivity mode. As ETD 
reagent 1,4- dicyanobenzene was used, which was delivered by a flow of nitrogen gas 
(makeup flow: 30 ml/min). The glow discharge ion source was operated at 60 µA, with refill 
times of 100 ms between 1 s MS/MS scans. The selection window for MS/MS mode was ± 2.0 
m/z units. The trap T-Wave ion guide was operated with a wave height of 0.2 V and a wave 
velocity of 300 m/s. Spectra were measured over 10 min in the range of m/z 50 – 3500 by 
selecting the 5+ charged peptides as MS/MS precursor for ETD. Further parameters were: 
capillary voltage (2.8 kV), sampling cone (20-22 V), extraction cone (2.0 V), source 
temperature (90°C), desolvation gas temperature (300°C), cone gas (0 L/h), desolvation gas 
(800 L/h), transfer collision voltage (5.0) and gas control (trap 14 ml/min and transfer 0.3 
ml/min). ETD was started by decreasing the wave height voltage from 1.5 V to 0.2 V. All 
experiments were done at least in triplicate. For ETD spectra data evaluation, the ETD 
Fragment Analyzer module of the software suite MassMap® (MassMap GmbH & Co. KG, 
Wolfratshausen, Germany) was used. It is based on GRAMS/AI (Thermo Fisher Scientific, 
Waltham (MA), USA). ETD spectra over 10 min were combined and evaluated as described in 
detail previously (Yucel et al., 2019). 
 
Molecular dynamics (MD) simulations 
TNFα22-62 WT, TNFα22-62 S34A, TNFα22-62 S34P and TNFα22-62 AGA/LLL model 
peptides with neutral termini were analysed in a fully hydrated POPC bilayer. Because no 
experimental structures were available for the TNFα WT TM domain and the mutants, we used 
a stochastic sampling protocol to generate a set of  start conformations (for details, see (Gotz 
et al., 2019). The sampled conformations were hierarchically clustered, and the centroid of the 
cluster with the highest population was placed in a symmetric bilayer, consisting of 128 POPC 
lipids (90waters/lipid, ionic strength), using protocols as provided by CHARMM-GUI (Lee et al., 
2016). Simulations of 2 µs length (T = 303.15 K, p = 0.1 MPa, integration time step 2fs) were 
performed using GROMACS 2019.3 (Berendsen et al., 1995). Frames were recorded every 
10 ps. Only the last 1 µs of the trajectory were subjected to analysis. All simulations use the 
CHARMM36 force field (Best et al., 2012). Analysis of the H-bond occupancies and helix tilt 
angles were performed as described in our previous work (Gotz et al., 2019, Götz et al., 2019). 
For secondary structure analysis, we used the DSSP algorithm (Kabsch and Sander, 1983). 
Helix backbone conformations and location of hinge regions were analysed with the program 
Dyndom (Hayward and Lee, 2002). A straight helix was used as a reference structure for the 
analysis of the conformational ensembles from NMR and MD. This reference was determined 
from the average structure of the TNFα22-62 WT peptide in POPC. For structural visualization 
in Figs 8 and Supp 7 Visual Molecular Dynamics was used (Humphrey et al., 1996). 
 
Solution NMR 
Dry TNFα28-60 wt, S34P and AGA/LLL peptides were dissolved in 500 µL HFIP, 5 mM TCEP 
was added to reduce potential disulfide bridges and the pH was adjusted between 4 to 5 by 
adding NaOH. The solvent was removed by lyophilization and the dry peptide film was 
dissolved in 500 μL 80% TFE-d2 and 20% dH2O with renewed addition of 5 mM TCEP. The 
pH was finally adjusted to 6.5. Peptide concentration ranged between 2 to 4 mg/mL (500 µM 
to 1 mM).  
NMR spectra of peptides were recorded on a 600 MHz AVANCE III spectrometer (Bruker 
BioSpin, Rheinstetten, Germany) equipped with a TXI cryoprobe at a temperature of 303 K. 
To assign 1H and 13C-resonances of the peptides a set of two-dimensional spectra was 
recorded: 1H-1H-TOCSY with a mixing time of 60 ms, 1H-1H-NOESY with a mixing time of 200 
ms and natural abundance 1H-13C-HSQC. Spectra were recorded with 48 scans and 1000 data 
points in the indirect dimension. 1H and 13C chemical shifts are referenced to TFE. The NMR 
spectra were processed with TopSpin 3.5 pl 7 (Bruker BioSpin, Rheinstetten, Germany) and 
analyzed using CcpNmr Analysis (Vranken et al., 2005). Dihedral restraints for Φ and Ψ 
backbone dihedral angles were derived from chemical shift data using the program TALOS+ 
(Shen et al., 2009). All structure calculations were performed with CNS(Brunger et al., 1998) 
using the ARIA2 setup (Rieping et al., 2007). PyMOL (http://www.pymol.org) was used to 
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